Subgroup analyses revealed a substantial decline in serum CRP levels among healthy and unhealthy participants with obesity and baseline serum CRP levels >3 mg/L in long-term (≥12 weeks) supplementation with high doses of SIL (Table 2). This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.